Cargando…
Exopolysaccharides of Bacillus amyloliquefaciens Amy-1 Mitigate Inflammation by Inhibiting ERK1/2 and NF-κB Pathways and Activating p38/Nrf2 Pathway
Bacillus amyloliquefaciens is a probiotic for animals. Evidence suggests that diets supplemented with B. amyloliquefaciens can reduce inflammation; however, the underlying mechanism is unclear and requires further exploration. The exopolysaccharides of B. amyloliquefaciens amy-1 displayed hypoglycem...
Autores principales: | Sung, Wei-Wen, Lin, Yun-Yu, Huang, Shen-Da, Cheng, Hsueh-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499622/ https://www.ncbi.nlm.nih.gov/pubmed/36142159 http://dx.doi.org/10.3390/ijms231810237 |
Ejemplares similares
-
Production and Characterisation of an Exopolysaccharide by Bacillus amyloliquefaciens: Biotechnological Applications
por: Sánchez-León, Enrique, et al.
Publicado: (2023) -
Lactic Acid Bacteria-Derived Exopolysaccharides Mitigate the Oxidative Response via the NRF2-KEAP1 Pathway in PC12 Cells
por: Şirin, Seda
Publicado: (2023) -
Antitumor activity of bacterial exopolysaccharides from the endophyte Bacillus amyloliquefaciens sp. isolated from Ophiopogon japonicus
por: CHEN, YI-TAO, et al.
Publicado: (2013) -
Physalin A regulates the Nrf2 pathway through ERK and p38 for induction of detoxifying enzymes
por: Shin, Ji Min, et al.
Publicado: (2019) -
Acidic Exopolysaccharide Produced from Marine Bacillus amyloliquefaciens 3MS 2017 for the Protection and Treatment of Breast Cancer
por: Ibrahim, Abeer Y, et al.
Publicado: (2020)